Menu
Back to Archived Journals » Biosimilars » Volume 5
Original Research
Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim TPI G-CSF in comparison to the marketed reference filgrastim Neupogen®: a double-blind, single-dose, two-period crossover trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,218 | Dovepress* | 18,218+ | 1,173 | 19,391 | |
| Totals | 18,218 | 1,173 | 19,391 | ||
|
*Since 3 November 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on Google Scholar